Logo

Element Biosciences Aviti FIT Suite

Aug 17, 2023

Element Biosciences has launched Aviti Fit, a suite of products to provide more flexibility on its Aviti instrument. 

The Aviti LT (low-throughput) is an instrument configured to run only low- and medium-throughput sequencing kits. It can be upgraded later to run the full lineup of kits. New sequencing kits include a 1 billion-read 2x75 bp kit, 250 million- and 500 million-read 2x150 bp kits, and 300 million- and 100 million-read 2x300 bp kits. Some new kits will offer two individually addressable lanes.

The firm is also launching Elembio Cloud, an online platform for managing instruments, monitoring runs with real-time updates, and visualizing run metrics and data to gauge run performance.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.